Sienkiewicz, K.; Burzyńska, M.; Rydlewska-Liszkowska, I.; Sienkiewicz, J.; Gaszyńska, E.
The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process. Int. J. Environ. Res. Public Health 2022, 19, 413.
https://doi.org/10.3390/ijerph19010413
AMA Style
Sienkiewicz K, Burzyńska M, Rydlewska-Liszkowska I, Sienkiewicz J, Gaszyńska E.
The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process. International Journal of Environmental Research and Public Health. 2022; 19(1):413.
https://doi.org/10.3390/ijerph19010413
Chicago/Turabian Style
Sienkiewicz, Kamila, Monika Burzyńska, Izabela Rydlewska-Liszkowska, Jacek Sienkiewicz, and Ewelina Gaszyńska.
2022. "The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process" International Journal of Environmental Research and Public Health 19, no. 1: 413.
https://doi.org/10.3390/ijerph19010413
APA Style
Sienkiewicz, K., Burzyńska, M., Rydlewska-Liszkowska, I., Sienkiewicz, J., & Gaszyńska, E.
(2022). The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process. International Journal of Environmental Research and Public Health, 19(1), 413.
https://doi.org/10.3390/ijerph19010413
